Publication | Open Access

Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone

Cancer Endocrine TherapyBreast OncologyMedicinePharmacologyNeuroendocrine DisorderPhase Ii StudyBreast CancerEndocrinologyOncologyRadiation OncologyMelatoninEndocrine-related Cancer